Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease (2022)
Attributed to:
A high-throughput crystallisation facility for protein structure determination
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.apsb.2022.06.002
PubMed Identifier: 35702321
Publication URI: http://europepmc.org/abstract/MED/35702321
Type: Journal Article/Review
Parent Publication: Acta Pharmaceutica Sinica B
Issue: 10
ISSN: 22113843 22113835